X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ALKS

Closed

Alkermes Plc

28.985
+0.375 (+1.31%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 28.61
Day's Range: 28.485 - 30.
Send
When Written:
 
28.19
Alkermes Plc is a biopharmaceutical company that specializes in the development and commercialization of innovative medicines for the treatment of central nervous system (CNS) disorders, such as schizophrenia, depression, addiction, and multiple sclerosis. The company was founded in 1987 and is headquartered in Dublin, Ireland, with additional operations in the United States. Alkermes has a portfolio of approved products and pipeline candidates, including VIVITROL for the treatment of opioid and alcohol dependence, ARISTADA for the treatment of schizophrenia, and ALKS 5461 for the treatment of major depressive disorder. The company employs over 2,000 people worldwide and is committed to advancing science and improving the lives of patients living with CNS disorders.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X